Survival analysis revealed that high ELFN1 CNV levels were associated with worse survival in CHOL, GBM, HNSC, LGG, and UCEC, while low CNV levels correlated with better survival in KIRP and LUSC (Figures 4B, C). This evidence concerns the gene ELFN1 and glioblastoma.